Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...

Savara says it will in the first of half next year seek an FDA license to treat autoimmune pulmonary alveolar proteinosis ...

Molgramostim is in phase 3 clinical trials to treat autoimmune pulmonary alveolar proteinosis, or aPAP. Molgramostim has received an FDA orphan drug designation — given to drugs targeting rare ...

After hours: September 23 at 7:33 PM EDT Loading Chart for SVRA ...

A scalloped tongue, also known as a crenated tongue, presents wavy indentations along the sides. These indentations, called ...

ARP Atlases. 2007;1:17-47. The total number of leukocytes recovered by lavage is determined by examination of a sample of the pooled fluid with a hemocytometer. The cell counts are most accurate ...